This month, our app reviewer selected the top 5 depression apps that you and your patients can use. Which ones made the cut?
Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care
Psychiatric comorbidities affect 25% of AD patients. Here, a check list on when to screen, when to refer, and how to prevent accumulated psychological burden in primary care.
Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes
Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.
Meta-Analysis Finds High Uptake but Moderate Adherence in Clinical Trials of Depression and Anxiety Apps
Mental health apps show high initial uptake but moderate adherence, revealing key factors for improving user retention in clinical trials.
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression
Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.
Intervene Early in AD to Avoid Lasting Psychological Impact
Controlling atopic dermatitis signs and symptoms early can alter social, emotional, and functional outcomes, sometimes dramatically.
Emotional Red Flags in Atopic Dermatitis: What to Screen For
Emotional red flags in AD, eg, sleep loss, isolation, hopelessness, often go unseen. Quick screening questions can surface the real burden individuals carry.